Pulmonary abnormalities in patients intravenously receiving the methanol extraction residue (MER) of bacillus calmette‐guerin

Jorge R. Quesada, Herman I. Libshitz, Evan M. Hersh, Jordan U. Gutterman

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

Eight of 64 patients receiving intravenous administration of methanol extraction residue (MER) of Bacillus Calmette‐Guerin (BCG), developed miliary‐type pulmonary parenchymal changes. The clinical and radiological characteristics are described. An increased incidence was noted in patients with a history of previous BCG exposure or with positive PPD skin reactivity. Spontaneous resolution was observed upon discontinuation of MER. These changes most likely represent a granulomatous inflammatory process, although no histological confirmation was obtained.

Original languageEnglish (US)
Pages (from-to)1340-1343
Number of pages4
JournalCancer
Volume45
Issue number6
DOIs
StatePublished - Mar 15 1980

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Pulmonary abnormalities in patients intravenously receiving the methanol extraction residue (MER) of bacillus calmette‐guerin'. Together they form a unique fingerprint.

  • Cite this